Connecting Innovation
Creating Value
Advancing globally sourced therapeutic innovations through strategic licensing, development, and partnerships.
Embedded Files
Our Approach
Building a Multi-Modality Pipeline
Building a Multi-Modality Pipeline
BioAuraGen identifies global, novel technologies to reduce the risk of therapeutic product attrition during development and commercialization. Through strategic collaborations and partnerships, we establish proof of concept, demonstrate safety profiles, and deliver efficacious, life-changing therapeutics, thereby ensuring meaningful market access.
Current licensed dual-targeting CAR-T technologies is to be expanded into next-generation modalities, including TCEs and ADCs.
Why Partner with Us
Why Partner with Us
Global Innovation → Licensing/Acquisition → Development → Commercialization
Global Sourcing Network
Global Sourcing Network
Access to innovative therapeutic assets through a broad network of biotechnology companies, research organizations, and industry partners worldwide.
Strategic Asset Development
Strategic Asset Development
Leveraging scientific, clinical, and commercial expertise to advance promising therapeutic programs toward development and commercialization.
Partnership Expertise
Partnership Expertise
Proven expertise in licensing, strategic transactions, and partnerships that accelerate the development and commercialization of innovative therapies.
Page updated
Report abuse